Treacher Collins Syndrome (TCS) is a genetic disorder that affects the development of the head and face, and can cause severe physical and psychological challenges. It is a rare condition, with an estimated incidence of 1 in 50,000 live births. The condition was first described by English surgeon Edward Treacher Collins in 1900 and is also known as mandibulofacial dysostosis. This article will provide an overview of the condition, its diagnosis, and the medical and psychological challenges it presents. It will also tell the story of one individual's struggle with TCS and their ultimate triumph over the condition. Through this story, we will gain a greater understanding of the hope and resilience of those living with TCS and their families.
Treacher Collins Syndrome is a genetic disorder that affects the development of the face and head. It is caused by a mutation in the TCOF1 gene, which is responsible for the production of a protein called treacle. This protein is important for the development of the bones, muscles, and skin of the face and head. People with TCS typically have underdeveloped cheekbones, a small lower jaw, and a flattened bridge of the nose. They may also have downward-slanting eyes, notched or absent ears, a cleft palate, and a small chin.
Treacher Collins Syndrome is usually diagnosed prenatally through ultrasound or after birth through physical examination and genetic testing. A diagnosis of TCS is usually made by a combination of physical exam, family history, and genetic testing.
People with Treacher Collins Syndrome can experience a range of medical challenges. These can include hearing loss, breathing problems, feeding difficulties, and vision problems. People with TCS may require multiple surgeries to correct facial deformities and improve their breathing and feeding. These surgeries can be complex and require a multidisciplinary team of doctors, nurses, and therapists.
Living with Treacher Collins Syndrome can present a range of psychological challenges. These can include feelings of isolation, low self-esteem, and depression. People with TCS may also experience difficulties in school and social situations due to their physical differences. They may be the target of bullying or teasing, which can lead to further psychological distress.
The story of one individual's struggle with Treacher Collins Syndrome and their ultimate triumph over the condition can provide us with a greater understanding of the hope and resilience of those living with TCS and their families. This is the story of Sam*, a young man with Treacher Collins Syndrome. Sam was born with the condition and, as a result, had a cleft palate, underdeveloped cheekbones, and a small lower jaw. At a young age, Sam underwent multiple surgeries to correct his facial deformities and improve his breathing and feeding. These surgeries were difficult, both physically and emotionally, but Sam persevered and was determined to live a full and happy life. As he grew older, Sam faced the psychological challenges of living with Treacher Collins Syndrome. He experienced feelings of isolation, low self-esteem, and depression.
Treacher Collins Syndrome is a rare genetic disorder that affects the development of the head and face. It can cause physical and psychological challenges, but those living with TCS and their families can find hope and resilience. The story of one individual's struggle with the condition and their ultimate triumph provides us with a greater understanding of the hope and resilience of those living with TCS and their families.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation